Keyword search (3,448 papers available)


Data do not support sex as addictive.

Author(s): Prause N, Janssen E, Georgiadis J, Finn P, Pfaus J

Lancet Psychiatry. 2017 12;4(12):899 Authors: Prause N, Janssen E, Georgiadis J, Finn P, Pfaus J PMID: 29179928 [PubMed - indexed for MEDLINE]

Article GUID: 29179928
Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part II.

Author(s): Parish SJ, Goldstein AT, Goldstein SW, Goldstein I, Pfaus J, Clayton AH, Giraldi A, Simon JA, Althof SE, Bachmann G, Komisaruk B, Levin R, S...

J Sex Med. 2016 12;13(12):1888-1906 Authors: Parish SJ, Goldstein AT, Goldstein SW, Goldstein I, Pfaus J, Clayton AH, Giraldi A, Simon JA, Althof SE, Bachmann G, Komisaruk B, Levin R, Spadt SK, Ki...

Article GUID: 27843072
Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review.

Author(s): Goldstein I, Kim NN, Clayton AH, DeRogatis LR, Giraldi A, Parish SJ, Pfaus J, Simon JA, Kingsberg SA, Meston C, Stahl SM, Wallen K, Worsley R

Mayo Clin Proc. 2017 Jan;92(1):114-128 Authors: Goldstein I, Kim NN, Clayton AH, DeRogatis LR, Giraldi A, Parish SJ, Pfaus J, Simon JA, Kingsberg SA, Meston C, Stahl SM, Wallen K, Worsley R

Article GUID: 27916394
Title:Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part II.
Authors:Parish SJ,  Goldstein AT,  Goldstein SW,  Goldstein I,  Pfaus J,  Clayton AH,  Giraldi A,  Simon JA,  Althof SE,  Bachmann G,  Komisaruk B,  Levin R,  Spadt SK,  Kingsberg SA,  Perelman MA,  Waldinger MD,  Whipple B
Link:https://www.ncbi.nlm.nih.gov/pubmed/27843072?dopt=Abstract
Category:J Sex Med
PMID:27843072
Dept Affiliation: PSYCHOLOGY
1 Departments of Psychiatry and Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: shp9079@med.cornell.edu.
2 The Center for Vulvovaginal Disorders, Washington, DC, USA.
3 San Diego Sexual Medicine, San Diego, CA, USA.
4 Sexual Medicine, Alvarado Hospital, San Diego, CA, USA.
5 Center for Studies in Behavioral Neurobiology, Department of Psychology, Concordia University, Montréal, QC, Canada.
6 Departments of Psychiatry and Neurobehavioral Sciences and Obstetrics and Gynecology, University of Virginia, Charlottesville, VA, USA.
7 Sexological Clinic, Psychiatric Center Copenhagen, Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
8 George Washington University, Washington, DC, USA.
9 Case Western Reserve University School of Medicine, Cleveland, OH; Center for Marital and Sexual Health of South Florida, West Palm Beach, FL, USA.
10 Department of Obstetrics and Gynecology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
11 Department of Psychology, Rutgers University, Newark, NJ, USA.
12 Department of Physiology, University of Sheffield, Sheffield, UK.
13 Female Sexual Medicine, Academic Urology Center for Pelvic Medicine, Bryn Mawr, PA; Department of Obstetrics and Gynecology, Drexel University College of Medicine, Philadelphia, PA, USA.
14 Departments of Reproductive Biology and Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
15 Department of Psychiatry, Reproductive Medicine and Urology, Weill Cornell Medicine; Human Sexuality Program, New York Presbyterian Hospital, New York, NY, USA.
16 Department of Pharmacology and Physiology, Drexel University School of Medicine, Philadelphia, PA, USA.
17 Rutgers University, New Brunswick, NJ, USA.

Description:

Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part II.

J Sex Med. 2016 12;13(12):1888-1906

Authors: Parish SJ, Goldstein AT, Goldstein SW, Goldstein I, Pfaus J, Clayton AH, Giraldi A, Simon JA, Althof SE, Bachmann G, Komisaruk B, Levin R, Spadt SK, Kingsberg SA, Perelman MA, Waldinger MD, Whipple B

Abstract

INTRODUCTION: Current Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) definitions of sexual dysfunction do not identify all sexual problems experienced clinically by women and are not necessarily applicable for biologic or biopsychosocial management of female sexual dysfunction. A unified nomenclature system enables clinicians, researchers, and regulatory agencies to use the same language and criteria for determining clinical end points, assessing research results, and managing patients.

AIM: To develop nomenclature with classification systems for female sexual desire, arousal, and orgasm disorders with definitions pertinent to clinicians and researchers from multiple specialties who contribute to the field of sexual medicine.

METHODS: Key national and international opinion leaders diverse in gender, geography, and areas of expertise met for 2 days to discuss and agree to definitions of female sexual desire, arousal, and orgasm disorders and persistent genital arousal disorder. The attendees consisted of 10 psychiatrists and psychologists; 12 health care providers in specialties such as gynecology, internal medicine, and sexual medicine; three basic scientists; and one sexuality educator, representing an array of societies working within the various areas of sexual function and dysfunction.

MAIN OUTCOME MEASURE: A unified set of definitions was developed and accepted for use by the International Society for the Study of Women's Sexual Health (ISSWSH) and members of other stakeholder societies participating in the consensus meeting.

RESULTS: Current DSM-5 definitions, in particular elimination of desire and arousal disorders as separate diagnoses and lack of definitions of other specific disorders, were adapted to create ISSWSH consensus nomenclature for distressing sexual dysfunctions. The ISSWSH definitions include hypoactive sexual desire disorder, female genital arousal disorder, persistent genital arousal disorder, female orgasmic disorder, pleasure dissociative orgasm disorder, and female orgasmic illness syndrome.

CONCLUSION: Definitions for female sexual dysfunctions that reflect current science provide useful nomenclature for current and future management of women with sexual disorders and development of new therapies.

PMID: 27843072 [PubMed - indexed for MEDLINE]